# Reduction in Ocular Surface Culture Positivity Following Short-Term Treatment with Liposomal Ozonated Oil Eyedrops

**Authors:** Andreea-Talida Tirziu, Maria-Alexandra Preda, Aimee Rodica Chis, Ionela-Iasmina Yasar, Norberth-Istvan Varga, Florin George Horhat, Mihnea Munteanu, Rosca Cosmin

PMC · DOI: 10.3390/clinpract16030059 · Clinics and Practice · 2026-03-10

## TL;DR

Short-term use of liposomal ozonated oil eyedrops significantly reduced microbial presence on the ocular surface in a clinical study.

## Contribution

Demonstrates that liposomal ozonated oil eyedrops effectively reduce ocular surface microbial burden in real-world clinical settings.

## Key findings

- Culture positivity dropped from 86.1% to 10.9% after treatment.
- Microbiological clearance was observed in 87.4% of baseline-positive samples.
- No culture-negative cases became positive after treatment.

## Abstract

Background/Objectives: The ocular surface is continuously exposed to microorganisms, and disruption of host–microbial balance may lead to infection or postoperative complications. Increasing antimicrobial resistance and biofilm formation have highlighted the need for alternative or complementary non-antibiotic strategies to control ocular surface microbial burden. Liposomal ozonated oil eyedrops have demonstrated antimicrobial and antibiofilm activity in preclinical and preliminary clinical studies. The aim of this study was to evaluate changes in ocular surface microbiological culture results before and after treatment with liposomal ozonated oil eyedrops in a real-world clinical setting. Methods: This was a prospective, observational, real-world pre–post study including 101 eyes from 101 patients undergoing ocular surface microbiological sampling in routine clinical practice. Two samples were obtained per patient: Sample I immediately before treatment and Sample II at the routine follow-up visit after short-course treatment with liposomal ozonated oil eyedrops (1 drop, four times daily, for 4 days). The interval between samples ranged from 3 to 5 days (median 3 days). Microbiological cultures were classified as positive or showing no growth. Paired changes in culture positivity were analyzed using McNemar’s exact test. Results: At baseline, 87 of 101 samples (86.1%) yielded positive cultures, while 14 (13.9%) showed no growth. Following treatment, culture positivity decreased to 11 of 101 samples (10.9%), with 90 samples (89.1%) showing no growth. Among baseline-positive samples, microbiological clearance was observed in 76 cases (87.4%). No cases converted from culture-negative to culture-positive at follow-up. The reduction in culture positivity after treatment was statistically significant (McNemar’s exact test, p < 0.001). Recent antibiotic exposure within 14 days prior to baseline sampling was reported in 8 patients (7.9%). Persistent positive cultures were observed in a minority of cases and were mainly associated with common ocular surface pathogens. Conclusions: In routine clinical practice, short-term treatment with liposomal ozonated oil eyedrops was associated with a significant reduction in ocular surface culture positivity over a short follow-up interval.

## Full-text entities

- **Diseases:** TBUT (MESH:D019457), conjunctival hyperemia (MESH:D003229), epithelial toxicity (MESH:D002277), ocular surface irritation (MESH:D001523), staphylococcal (MESH:D011023), dysbiosis (MESH:D064806), blepharitis (MESH:D001762), photophobia (MESH:D020795), cataract (MESH:D002386), coagulase-negative staphylococci (MESH:D064726), fungal (MESH:D009181), postoperative complications (MESH:D011183), infection (MESH:D007239), HIV infection (MESH:D015658), injury to (MESH:D014947), conjunctivitis (MESH:D003231), hyperemia (MESH:D006940), hypersensitivity (MESH:D004342), corneal epithelial defects (MESH:C536444), ocular surface disease (MESH:D010534), Ocular surface infections (MESH:D015817), keratitis (MESH:D007634)
- **Chemicals:** chlorhexidine (MESH:D002710), lipid (MESH:D008055), agar (MESH:D000362), disodium edetate (MESH:D004492), ozone (MESH:D010126), boric acid (MESH:C032688), hydroxypropyl methylcellulose (MESH:D065347), methicillin (MESH:D008712), Desodrop (-), hypochlorous acid (MESH:D006997), liposomal (MESH:C050797), water (MESH:D014867), ozonides (MESH:C503429), Fluorescein (MESH:D019793), CO2 (MESH:D002245), sodium tetraborate (MESH:C010634), phospholipids (MESH:D010743), PHMB (MESH:C031233), unsaturated fatty acids (MESH:D005231), povidone-iodine (MESH:D011206), reactive oxygen species (MESH:D017382)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Staphylococcus haemolyticus (species) [taxon 1283], Enterococcus faecalis (species) [taxon 1351], Escherichia coli (E. coli, species) [taxon 562], Moraxella catarrhalis (species) [taxon 480], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13026013/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC13026013/full.md

---
Source: https://tomesphere.com/paper/PMC13026013